Cytek Biosciences Files 8-K on Financials
Ticker: CTKB · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1831915
| Field | Detail |
|---|---|
| Company | Cytek Biosciences, Inc. (CTKB) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: CYTK
TL;DR
CYTK filed an 8-K for financial updates, nothing major detailed yet.
AI Summary
On February 27, 2025, Cytek Biosciences, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing indicates Cytek Biosciences is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial reporting and does not appear to contain any immediately alarming information.
Key Players & Entities
- Cytek Biosciences, Inc. (company) — Registrant
- February 27, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-40632 (string) — SEC File Number
- 47-2547526 (string) — IRS Employer Identification No.
- 47215 Lakeview Boulevard Fremont, California 94538 (address) — Principal Executive Offices
- (877) 922-9835 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported in this 8-K?
The provided excerpt indicates the 8-K concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail specific figures.
When was this 8-K report filed?
The report was filed on February 27, 2025.
What is the primary purpose of this 8-K filing for Cytek Biosciences, Inc.?
The filing is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on the company's results of operations and financial condition.
Where is Cytek Biosciences, Inc. headquartered?
The company's principal executive offices are located at 47215 Lakeview Boulevard, Fremont, California 94538.
What is Cytek Biosciences, Inc.'s SEC file number?
Cytek Biosciences, Inc.'s SEC file number is 001-40632.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding Cytek Biosciences, Inc. (CTKB).